CN101843829B - Chinese medicament for treating pulmonary heart diseases - Google Patents

Chinese medicament for treating pulmonary heart diseases Download PDF

Info

Publication number
CN101843829B
CN101843829B CN2009102383040A CN200910238304A CN101843829B CN 101843829 B CN101843829 B CN 101843829B CN 2009102383040 A CN2009102383040 A CN 2009102383040A CN 200910238304 A CN200910238304 A CN 200910238304A CN 101843829 B CN101843829 B CN 101843829B
Authority
CN
China
Prior art keywords
parts
chinese medicine
chinese
chinese medicament
angelica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102383040A
Other languages
Chinese (zh)
Other versions
CN101843829A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rugao Binjiang Urban Construction Investment Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102383040A priority Critical patent/CN101843829B/en
Publication of CN101843829A publication Critical patent/CN101843829A/en
Application granted granted Critical
Publication of CN101843829B publication Critical patent/CN101843829B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating pulmonary heart diseases and belongs to the field of Chinese medicaments for treating respiratory diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: snakegourd fruit, Chinese angelica, loguat leaf, fritillaria, tangerine peel, radix pseudo-ginseng, root of rehmannia, lucid ganoderma and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, clearing lung and eliminating phlegm, and depurating lung and relieving asthma, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

一种治疗肺心病的中药Chinese medicine for treating pulmonary heart disease

技术领域technical field

本发明属于治疗呼吸病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating respiratory diseases.

背景技术Background technique

现有的用于治疗肺心病的中药方面,存在两个方面的不足:一是治疗效果不够明显,二是见效比较迟缓,以致于大批肺心病患者长期在胸闷、心悸、呼吸困难中度日,下肢浮肿,咳嗽气短,多年不能缓解,患者及其家属对此不满意。There are two deficiencies in existing traditional Chinese medicines for treating cor pulmonale: one is that the therapeutic effect is not obvious enough, and the other is that the effect is relatively slow, so that a large number of cor pulmonale patients suffer from chest tightness, palpitations, and dyspnea for a long time. The lower extremity edema, cough and shortness of breath have not been relieved for many years, and the patient and his family are not satisfied with this.

针对以上提出的问题,本发明提供一种治疗肺心病的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。Aiming at the problems raised above, the present invention provides a kind of Chinese medicine for treating cor pulmonale, which can solve the problem that the effect of this kind of traditional Chinese medicine is not obvious enough and the effect is relatively slow in the past. It has good effect, quick effect, remarkable effect and definite drug effect. The advantage of quicker results.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗肺心病的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of cor pulmonale, adopts Chinese medicine raw material to prepare, and formula is (by weight):

瓜蒌4-30份    当归4-30份    枇杷叶3-20份Gualou 4-30 parts Angelica 4-30 parts Loquat leaves 3-20 parts

贝母4-30份    陈皮3-20份    三七3-20份Fritillaria 4-30 parts Chenpi 3-20 parts Panax notoginseng 3-20 parts

生地4-30份    灵芝2-12份Rehmannia 4-30 parts Ganoderma lucidum 2-12 parts

这种治疗肺心病的中药是由下列方法制成的:This traditional Chinese medicine for treating cor pulmonale is made by the following methods:

(1)按上述重量比,将瓜蒌、当归、枇杷叶、贝母、陈皮、生地经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, Trichosanthes, Angelica, Loquat Leaf, Fritillaria, Tangerine Peel, and Rehmannia Root are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝、生地扶正培本,益气养血,养心安神,增强机体免疫力;当归、三七生血养血,活血化瘀,加强心肺组织微循环;辅以瓜蒌、贝母清肺化痰;陈皮理气疏滞;枇杷叶肃肺平喘。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,清肺化痰,肃肺平喘之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum and Shengdi Fuzheng Peiben can nourish qi and blood, nourish the heart and calm the nerves, and enhance the body's immunity; Angelica and Panax notoginseng can generate blood and nourish blood, promote blood circulation and remove blood stasis, and strengthen the microcirculation of the heart and lung tissue; supplemented with Gualou and Fritillary Qing lungs and phlegm; tangerine peel regulates qi and stagnates; loquat leaf relieves lungs and relieves asthma. All the medicines are compatible and complement each other. They play the role of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, clearing lung and reducing phlegm, clearing lung and relieving asthma. The effect is good and quick. The advantages.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

瓜蒌80克    当归80克    枇杷叶60克Gualou 80 grams Angelica 80 grams Loquat leaves 60 grams

贝母80克    陈皮60克    三七60克Fritillaria 80g, Tangerine Peel 60g, Panax notoginseng 60g

生地80克    灵芝40克Raw ground 80g Ganoderma lucidum 40g

按规定重量,用常规水提取工艺将瓜蒌、当归、枇杷叶、贝母、陈皮、生地提取,制成浸膏细粉132克,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊828粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, use the conventional water extraction process to extract Trichosanthes, Angelica, Loquat leaves, Fritillaria, Tangerine Peel, and Habitat to make 132 grams of extract powder. The fine powder is mixed, stirred evenly, made into fine particles, packed into No. 0 capsules, and made into 828 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

瓜蒌160克    当归160克    枇杷叶120克160 grams of melon, 160 grams of angelica, 120 grams of loquat leaves

贝母160克    陈皮120克    三七120克Fritillaria 160g, Chenpi 120g, Panax notoginseng 120g

生地160克    灵芝60克Raw ground 160g Ganoderma lucidum 60g

按上述同样的方法,制成中药胶囊1585粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1585 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

瓜蒌300克    当归300克    枇杷叶200克300 grams of melon, 300 grams of angelica, 200 grams of loquat leaves

贝母300克    陈皮200克    三七200克Fritillaria 300g, Chenpi 200g, Panax notoginseng 200g

生地300克    灵芝120克300 grams of raw land, 120 grams of Ganoderma lucidum

按上述同样的方法,制成中药胶囊2857粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2857 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

瓜蒌7份    当归7份    枇杷叶4份7 parts of melon, 7 parts of angelica, 4 parts of loquat leaves

贝母7份    陈皮4份    三七4份7 parts of mother-of-pearl 4 parts of tangerine peel 4 parts of Panax notoginseng

生地7份    灵芝3份7 parts of raw land 3 parts of Ganoderma lucidum

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

瓜蒌20份    当归20份    枇杷叶12份20 parts of Gualou, 20 parts of Angelica, 12 parts of Loquat Leaf

贝母20份    陈皮12份    三七12份20 parts of Fritillaria, 12 parts of Chenpi, 12 parts of Panax notoginseng

生地20份    灵芝8份20 parts of raw land 8 parts of Ganoderma lucidum

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医肺心病为例,经9例临床观察。选择中医诊断肺心病为标准:体质虚弱,肢体无力,胸闷胸痛,咳嗽气短,呼吸困难,下肢浮肿。如上症状,即可确诊。在确诊观察的对象中,男性6例,女性3例,无其它严重疾病,年龄为57岁-79岁,平均年龄67.2岁。The present invention takes pulmonary heart disease of traditional Chinese medicine as an example, through 9 clinical observations. TCM diagnosis of cor pulmonale was selected as the standard: physical weakness, limb weakness, chest tightness and chest pain, cough, shortness of breath, dyspnea, and edema of the lower limbs. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 6 males and 3 females, without other serious diseases, aged 57-79 years, with an average age of 67.2 years.

疗效判定:Judgment of curative effect:

1、显效:体质增强,身上有劲,胸闷胸痛、呼吸困难等症状明显缓解。1. Significant effect: Physical fitness is enhanced, body is strong, chest tightness, chest pain, dyspnea and other symptoms are obviously relieved.

2、有效:体质增强,胸闷胸痛、呼吸困难等症状有所缓解。2. Effective: Physical fitness is enhanced, chest tightness, chest pain, dyspnea and other symptoms are relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日3次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用3个月后,症状明显改善。临床实验的9人中,显效4人,有效4人,无效1人,总有效率88.8%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 3 times a day, 4 capsules each time, each capsule contains 0.28 grams of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 3 months of taking, Symptoms improved significantly. Among the 9 people in the clinical trial, 4 were markedly effective, 4 were effective, and 1 was ineffective, with a total effective rate of 88.8%.

Claims (1)

1.一种治疗肺心病的中药,采用中药原料制备,其特征是,它是以下列重量比的组分制成的:1. a kind of Chinese medicine for the treatment of cor pulmonale, adopts Chinese medicine raw material to prepare, is characterized in that, it is made with the component of following weight ratio: 瓜蒌4-30份    当归4-30份    枇杷叶3-20份Gualou 4-30 parts Angelica 4-30 parts Loquat leaves 3-20 parts 贝母4-30份    陈皮3-20份    三七3-20份Fritillaria 4-30 parts Chenpi 3-20 parts Panax notoginseng 3-20 parts 生地4-30份    灵芝2-12份Rehmannia 4-30 parts Ganoderma lucidum 2-12 parts 这种治疗肺心病的中药是由下列方法制成的:This traditional Chinese medicine for treating cor pulmonale is made by the following methods: (1)按上述重量比,将瓜蒌、当归、枇杷叶、贝母、陈皮、生地经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, Trichosanthes, Angelica, Loquat Leaf, Fritillaria, Tangerine Peel, and Rehmannia Root are extracted through a conventional water extraction process to make extract powder; (2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,制成中药颗粒剂、散剂、胶囊剂、水丸剂、片剂剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; make traditional Chinese medicine granules, powders, capsules, water pills, and tablet dosage forms as required .
CN2009102383040A 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases Expired - Fee Related CN101843829B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102383040A CN101843829B (en) 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102383040A CN101843829B (en) 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases

Publications (2)

Publication Number Publication Date
CN101843829A CN101843829A (en) 2010-09-29
CN101843829B true CN101843829B (en) 2011-06-29

Family

ID=42768767

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102383040A Expired - Fee Related CN101843829B (en) 2009-11-18 2009-11-18 Chinese medicament for treating pulmonary heart diseases

Country Status (1)

Country Link
CN (1) CN101843829B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435794A (en) * 2014-09-23 2015-03-25 牛欣青 Electuary for treating chronic pulmonary heart disease and preparation method thereof
CN105288193A (en) * 2015-11-25 2016-02-03 李涛 Yin nourishing and heat clearing preparation for treating pulmonary heart diseases, and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537114A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating arrhythmia
CN101537068A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating angina

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537114A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating arrhythmia
CN101537068A (en) * 2008-03-19 2009-09-23 北京绿源求证科技发展有限责任公司 Chinese medicine for treating angina

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
冷建春.益气活血法在肺心病剂型发作期的临床应用.《中西医结合心脑血管病杂志》.2004,第2卷(第10期), *
才晓茹等.中医药为主治疗肺心病心力衰竭的临床研究进展.《中西医结合心脑血管病杂志》.2005,第3卷(第9期), *

Also Published As

Publication number Publication date
CN101843829A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101843804A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843747B (en) Chinese medicament for treating rheumatoid arthritis
CN101843712B (en) Chinese medicament for treating angina
CN101843738A (en) Chinese medicament for treating diabetic feet
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101850017B (en) Chinese medicament for treating asthma
CN101884704B (en) Traditional Chinese medicine for treating asthma
CN101843717B (en) Chinese medicament for treating coronary disease
CN101874851B (en) Traditional Chinese medicine for treating chronic infectious arthritis
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843715A (en) Chinese medicament for treating diabetic feet
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101850083B (en) Chinese medicament for treating asthma
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101850079B (en) Chinese medicament for treating asthma
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101843720B (en) Chinese medicament for treating angina
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843793B (en) Chinese medicament for treating tachycardia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130701

Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166.

Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110629

Termination date: 20151118

CF01 Termination of patent right due to non-payment of annual fee